PMID: 8951827Dec 1, 1996Paper

Reading speed in pure alexia

Neuropsychologia
J R Hanley, J Kay

Abstract

This study investigated possible causes of differences in reading speed between two alexic patients who read words letter by letter. As both patients appeared to rely on serial left-to-right processing of letters within words, the difference in reading speed did not seem to be related to any differences in the extent to which the patients could recognize letters in words in parallel or 'ends-in'. Differences in reading speed also seemed to be unrelated to the patients ability to identify individual letters since their letter recognition accuracy was very similar. Furthermore, although patient PD was significantly slower at reading words aloud than patient DC, PD was in fact significantly quicker than DC on a test that has previously been used to assess letter recognition skills in letter-by-letter readers. It is therefore concluded that PD reads words more slowly because of an additional impairment at the level of the word form system. The results therefore reinforce the distinction between Type 1 and Type 2 letter-by-letter readers that was first drawn by Patterson and Kay.

References

Mar 1, 1992·Neuropsychologia·J R Hanley, J Kay
Oct 1, 1990·Brain and Language·M BehrmannD Bub
Mar 1, 1980·Brain : a Journal of Neurology·E K Warrington, T Shallice
Jun 1, 1995·Brain : a Journal of Neurology·T E FeinbergD M Roane
Feb 1, 1993·Brain : a Journal of Neurology·H B CoslettH Schwartz
May 1, 1993·Neuropsychologia·M Arguin, D N Bub
Apr 1, 1992·Journal of Cognitive Neuroscience·P A Reuter-Lorenz, K Baynes
Sep 1, 1975·Memory & Cognition·S M Chambers, K I Forster

❮ Previous
Next ❯

Citations

Dec 15, 2006·Journal of the International Neuropsychological Society : JINS·Janet L Ingles, Gail A Eskes
Dec 15, 2007·Journal of the International Neuropsychological Society : JINS·Janet L Ingles, Gail A Eskes
Sep 1, 2001·Cognitive Neuropsychology·G W Humphreys, K Mayall
Dec 1, 2001·Cognitive Neuropsychology·M Montant, M Behrmann
Jan 1, 2006·Cognitive Neuropsychology·Daniel FisetEric McCabe
Dec 1, 2006·Cognitive Neuropsychology·Toby B CummingKim S Graham
Apr 18, 2008·Cognitive Neuropsychology·Cristina RosazzaTim Shallice
Feb 5, 2009·Neuropsychological Rehabilitation·Irene Ablinger, Frank Domahs
Jun 6, 2009·Brain : a Journal of Neurology·Tobias PflugshauptRené M Mueri
Feb 12, 2014·Cognitive Neuropsychology·Teresa Schubert, Michael McCloskey
Dec 8, 1998·Neuropsychologia·M BehrmannE B Sekuler
Aug 23, 2001·Neuropsychologia·M BehrmannJ J Barton
Apr 29, 2009·Neuropsychologia·Rachel H MycroftJanice Kay
Apr 28, 2004·NeuroImage·Laurent Cohen, Stanislas Dehaene
Jun 2, 2006·Neuropsychologia·Thomas Habekost, Randi Starrfelt
Apr 17, 2007·Neuropsychologia·Rebecca L Johnson, Keith Rayner
Sep 29, 2012·Neuropsychologia·Mohamed L SeghierCathy J Price
Apr 13, 2013·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Keir X X YongSebastian J Crutch
Apr 8, 2014·Cognitive Neuropsychology·Anna M WoollamsKaralyn E Patterson
May 8, 2014·Cognitive Neuropsychology·Thomas HabekostRandi Starrfelt
Mar 29, 2014·Cognitive Neuropsychology·Jason J S BartonCharlotte Hills
Mar 1, 1998·Cognitive Neuropsychology·Doriana Chialant, Alfonso Caramazza
Mar 1, 2004·Cognitive Neuropsychology·Thomas J McKeeff, Marlene Behrmann
Mar 1, 1998·Cognitive Neuropsychology·Marlene BehrmannJames Nelson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.